160 related articles for article (PubMed ID: 28327297)
21. Facile green synthesis of bismuth sulfide radiosensitizer
Nosrati H; Abhari F; Charmi J; Rahmati M; Johari B; Azizi S; Rezaeejam H; Danafar H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3832-3838. PubMed ID: 31556316
[TBL] [Abstract][Full Text] [Related]
22. High toxicity of Bi(OH)
Bogusz K; Tehei M; Cardillo D; Lerch M; Rosenfeld A; Dou SX; Liu HK; Konstantinov K
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():958-967. PubMed ID: 30274133
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle dose enhancement of synchrotron radiation in PRESAGE dosimeters.
Gagliardi FM; Franich RD; Geso M
J Synchrotron Radiat; 2020 Nov; 27(Pt 6):1590-1600. PubMed ID: 33147183
[TBL] [Abstract][Full Text] [Related]
24. Effective Radiotherapy in Tumor Assisted by
Yu H; Yang Y; Jiang T; Zhang X; Zhao Y; Pang G; Feng Y; Zhang S; Wang F; Wang Y; Wang Y; Zhang LW
ACS Appl Mater Interfaces; 2019 Aug; 11(31):27536-27547. PubMed ID: 31294958
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous multiscale Monte Carlo simulations for gold nanoparticle radiosensitization.
Martinov MP; Thomson RM
Med Phys; 2017 Feb; 44(2):644-653. PubMed ID: 28001308
[TBL] [Abstract][Full Text] [Related]
26. A review of bismuth-based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy.
Shahbazi-Gahrouei D; Choghazardi Y; Kazemzadeh A; Naseri P; Shahbazi-Gahrouei S
IET Nanobiotechnol; 2023 Jun; 17(4):302-311. PubMed ID: 37139612
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy.
Sisin NNT; Abdul Razak K; Zainal Abidin S; Che Mat NF; Abdullah R; Ab Rashid R; Khairil Anuar MA; Mohd Zainudin NH; Tagiling N; Mat Nawi N; Rahman WN
Int J Nanomedicine; 2019; 14():9941-9954. PubMed ID: 31908451
[TBL] [Abstract][Full Text] [Related]
28. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME
Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122
[TBL] [Abstract][Full Text] [Related]
29. Platelet-membrane-camouflaged bismuth sulfide nanorods for synergistic radio-photothermal therapy against cancer.
Chen Y; Zhao G; Wang S; He Y; Han S; Du C; Li S; Fan Z; Wang C; Wang J
Biomater Sci; 2019 Aug; 7(8):3450-3459. PubMed ID: 31268067
[TBL] [Abstract][Full Text] [Related]
30. Increased radiotoxicity in two cancerous cell lines irradiated by low and high energy photons in the presence of thio-glucose bound gold nanoparticles.
Soleymanifard S; Rostami A; Aledavood SA; Matin MM; Sazgarnia A
Int J Radiat Biol; 2017 Apr; 93(4):407-415. PubMed ID: 27921518
[TBL] [Abstract][Full Text] [Related]
31. Advances in modelling gold nanoparticle radiosensitization using new Geant4-DNA physics models.
Engels E; Bakr S; Bolst D; Sakata D; Li N; Lazarakis P; McMahon SJ; Ivanchenko V; Rosenfeld AB; Incerti S; Kyriakou I; Emfietzoglou D; Lerch MLF; Tehei M; Corde S; Guatelli S
Phys Med Biol; 2020 Nov; 65(22):225017. PubMed ID: 32916674
[TBL] [Abstract][Full Text] [Related]
32. Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer.
Deng J; Xu S; Hu W; Xun X; Zheng L; Su M
Biomaterials; 2018 Feb; 154():24-33. PubMed ID: 29120816
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation.
Zhao F; Ming J; Zhou Y; Fan L
Cancer Chemother Pharmacol; 2016 May; 77(5):963-72. PubMed ID: 27011212
[TBL] [Abstract][Full Text] [Related]
34. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy.
McMahon SJ; Hyland WB; Muir MF; Coulter JA; Jain S; Butterworth KT; Schettino G; Dickson GR; Hounsell AR; O'Sullivan JM; Prise KM; Hirst DG; Currell FJ
Radiother Oncol; 2011 Sep; 100(3):412-6. PubMed ID: 21924786
[TBL] [Abstract][Full Text] [Related]
35. Monte Carlo-based calculation of nano-scale dose enhancement factor and relative biological effectiveness in using different nanoparticles as a radiosensitizer.
Robatjazi M; Baghani HR; Rostami A; Pashazadeh A
Int J Radiat Biol; 2021; 97(9):1289-1298. PubMed ID: 34047663
[TBL] [Abstract][Full Text] [Related]
36. Optimising element choice for nanoparticle radiosensitisers.
McMahon SJ; Paganetti H; Prise KM
Nanoscale; 2016 Jan; 8(1):581-9. PubMed ID: 26645621
[TBL] [Abstract][Full Text] [Related]
37. Nanozyme-Incorporated Biodegradable Bismuth Mesoporous Radiosensitizer for Tumor Microenvironment-Modulated Hypoxic Tumor Thermoradiotherapy.
Zhang J; Liu Y; Wang X; Du J; Song K; Li B; Chang H; Ouyang R; Miao Y; Sun Y; Li Y
ACS Appl Mater Interfaces; 2020 Dec; 12(52):57768-57781. PubMed ID: 33326213
[TBL] [Abstract][Full Text] [Related]
38. Nanoscale radiotherapy with hafnium oxide nanoparticles.
Maggiorella L; Barouch G; Devaux C; Pottier A; Deutsch E; Bourhis J; Borghi E; Levy L
Future Oncol; 2012 Sep; 8(9):1167-81. PubMed ID: 23030491
[TBL] [Abstract][Full Text] [Related]
39. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study.
Cho SH
Phys Med Biol; 2005 Aug; 50(15):N163-73. PubMed ID: 16030374
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the local dose enhancement in the combination of proton therapy and nanoparticles.
Martínez-Rovira I; Prezado Y
Med Phys; 2015 Nov; 42(11):6703-10. PubMed ID: 26520760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
